New protein-tyrosine kinase inhibitor launched by Pfizer

摘要

A new oncology treatment has been launched by Pfizer this week.Sutent(sunitinib maleate)is,Pfizer says,the first cancer therapy to be launched in the UK for two indications.It is a protein-tyrosine kinase inhibitor with two second-line indications.